Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950137-04-004606
Filing Date
2004-06-02
Accepted
2004-06-02 17:27:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT c85954sv3.htm S-3 171022
2 OPINION OF OPPENHEIMER WOLFF & DONNELLY LLP c85954exv5w1.htm EX-5.1 4940
3 CONSENT OF DELOITTE & TOUCHE LLP c85954exv23w1.htm EX-23.1 1231
4 GRAPHIC c85954c8595400.gif GRAPHIC 10352
  Complete submission text file 0000950137-04-004606.txt   189496
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-116110 | Film No.: 04845240
SIC: 2836 Biological Products, (No Diagnostic Substances)